Critically ill and medically complex patients frequently exhibit profound physiologic derangements that drastically alter drug disposition. For each patient scenario describing a specific clinical state and medication class, select the most accurate primary pharmacokinetic consequence and the corresponding required modification to therapy.
- Massive crystalloid resuscitation in a patient with total body surface area burns receiving an intravenous hydrophilic antimicrobial with a naturally small volume of distribution.Expansion of the extracellular fluid compartment significantly increases the volume of distribution, requiring a proportionally larger initial loading dose to achieve target peak serum concentrations.
- Initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in a cardiogenic shock patient receiving a highly lipophilic and highly protein-bound sedative continuous infusion.Extensive sequestration of the drug into the polyvinyl chloride tubing and oxygenator membrane dramatically increases the apparent volume of distribution and clearance, often requiring substantial dose escalation.
- Severe nephrotic syndrome with an albumin level of in a patient receiving a highly protein-bound anticonvulsant with a low hepatic extraction ratio.Increased unbound fraction leads to enhanced total hepatic clearance, resulting in lower total drug concentrations but stable unbound (active) steady-state concentrations; monitor free levels without preemptively increasing the dose.
- Acute decompensated heart failure with a severely reduced cardiac index of in a patient receiving a continuous intravenous infusion of an antiarrhythmic with a high hepatic extraction ratio.Reduced hepatic blood flow proportionally decreases systemic clearance, risking toxic accumulation and necessitating a preemptive reduction in the maintenance infusion rate.
- Morbid obesity (BMI ) in a patient undergoing surgical induction with a single intravenous bolus of a highly lipophilic anesthetic agent.Excess adipose mass increases the volume of distribution and prolongs the terminal elimination half-life, though the duration of action of a single bolus remains determined primarily by rapid redistribution to lean tissues.
Cevap
The correct matches align specific pathophysiological states with their primary pharmacokinetic alterations: Burns expand extracellular fluid requiring higher hydrophilic loading doses. ECMO sequesters lipophilic drugs requiring dose escalation. Hypoalbuminemia with low-extraction drugs alters total clearance but spares free levels. Heart failure with high-extraction drugs reduces clearance requiring dose reduction. Obesity prolongs terminal half-life of lipophilic drugs without drastically altering single-bolus redistribution duration.
Each clinical scenario precisely matches the defining pharmacokinetic principle governing drug disposition in that state. Extracellular fluid shifts dictate hydrophilic loading doses; lipophilic hardware sequesters lipophilic drugs; protein binding alters total (but not free) clearance for capacity-limited drugs; organ perfusion dictates clearance for flow-limited drugs; and redistribution dictates single-bolus duration regardless of terminal half-life.
Adım Adım Çözüm
Anahtar Kavram
Complex physiological states predictably alter volume of distribution () and clearance (). Understanding whether a drug is flow-limited versus capacity-limited, hydrophilic versus lipophilic, and how devices like ECMO act as pharmacokinetic sinks is paramount for precision dosing in critical illness.